After 23 years, we are now building Zealand into a fully integrated independent commercial company and have the right finance, pipeline, and science in place to…
In Conversation
Our clients are always looking for new ways to tell the story about their company, their products and how to support patients
The innovation power that private enterprises have has to be used in the public healthcare system.
Italy and its researchers have created a good environment for science. However, the country needs to better focus on translating the knowledge and the quality of…
Over the years, we have developed a real expertise, predominantly in the cardiovascular field, but we will leverage this expertise to bring value to doctors and…
Our goals are threefold: Ensure that Greater Copenhagen is a continued growth engine for all of Denmark, Copenhagen becomes the most sustainable capital in the world,…
Denmark has a unique health data infrastructure with national registers and electronic medical journals for each patient. This data footprint is a true asset for Denmark…
[Denmark] has a prosperous future ahead if the divided healthcare sector can be unified, better conditions for value-based procurements are established, further financial support for the…
It is now crystal clear that a one-size-fits-all approach is not the way to go in oncology
Big and specialized hospitals in Denmark such as ours are in a unique position to continue conducting clinical trials due to the relatively high number of…
In the last couple of years, the Scandinavian life science industry has rapidly opened up and is now very willing to engage with society more broadly.…
CAR-T is not necessarily the best treatment option for everyone. There could be other second-best options for a certain group of patients. Our point of view…
